Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update
15.08.2022 - Early launch data for VTAMA (tapinarof) with approximately 14,000 prescriptions written by more than 3,000 unique prescribers in initial eleven weeks of launch shows strong demand for first topical novel chemical entity for plaque psoriasis in 25 ...
Source: wallstreet-online.de